Skip to main content

Written question asked by Laura Moffatt (Labour) on Friday, 12 September 2003, in the House of Commons. It was due for an answer on Monday, 6 October 2003. It was answered by Melanie Johnson (Labour) on Monday, 6 October 2003 on behalf of the Department of Health.


Dept of Health

Question
To ask the Secretary of State for Health, if he will make a statement on the impact on the NHS of catheter-associated infection in relation to vancomycin resistant enterocci. - Information not available centrally.
Answer

Laura Moffatt: To ask the Secretary of State for Health if he will make a statement on the impact on the NHS of catheter-associated infection in relation to vancomycin resistant enterocci. [130619] Miss Melanie Johnson: This information is not available centrally. Voluntary surveillance data1 show that almost two- thirds of blood stream infections of known origin were associated with an intravascular device or device-related infections, such as a catheter associated urinary tract infection. The second phase of the mandatory surveillance scheme for healthcare associated infection was recently introduced. From 1 September 2003, trusts will report blood stream infections due to glycopeptide resistant enterococci (including vancomycin resistant enterocci) and serious untoward incidents associated with infection. 1 Public Health Laboratory Service. Nosocomial Infection National Surveillance Service. Surveillance of hospital acquired bacteraemia in English hospitals. 1997-2002.


Secondary information

Type
Written question
Reference
410 c1271W; 130619
Session
2002-03
Subjects
Blood Infectious diseases Bacterial diseases Catheters
Link
View this Written question on www.publications.parliament.uk